Through a series of experiments on H9C2 cells, we verified that CLE can suppress myocardial ischemia-reperfusion injury by stimulating TLR4 and downstream PI3K/Akt signaling pathways to protect myocardial cells. This evidence concerns the gene AKT1 and myocardial ischemia.